[Federal Register Volume 86, Number 132 (Wednesday, July 14, 2021)]
[Notices]
[Page 37116]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-14955]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-53-2021]


Foreign-Trade Zone (FTZ) 93--Raleigh/Durham, North Carolina; 
Notification of Proposed Production Activity; Liebel-Flarsheim Company, 
LLC (Diagnostic Imaging Contrast Media); Raleigh, North Carolina

    The Triangle J Council of Governments, grantee of FTZ 93, submitted 
a notification of proposed production activity to the FTZ Board on 
behalf of Liebel-Flarsheim Company, LLC (Liebel-Flarsheim), located in 
Raleigh, North Carolina. The notification conforming to the 
requirements of the regulations of the FTZ Board (15 CFR 400.22) was 
received on June 30, 2021.
    Liebel-Flarsheim already has authority to produce diagnostic 
imaging contrast media within FTZ 93. The current request would add a 
finished product and a foreign status material to the scope of 
authority. Pursuant to 15 CFR 400.14(b), additional FTZ authority would 
be limited to the specific foreign-status material and specific 
finished product described in the submitted notification (as described 
below) and subsequently authorized by the FTZ Board.
    Production under FTZ procedures could exempt Liebel-Flarsheim from 
customs duty payments on the foreign-status material used in export 
production. On its domestic sales, for the foreign-status materials 
noted below and in the existing scope of authority, Liebel-Flarsheim 
would be able to choose the duty rate during customs entry procedures 
that applies to gadopiclenol (finished contrast media) (duty-free). 
Liebel-Flarsheim would be able to avoid duty on the foreign-status 
material which becomes scrap/waste. Customs duties also could possibly 
be deferred or reduced on foreign-status production equipment.
    The material sourced from abroad is gadopiclenol (active 
pharmaceutical ingredient) (duty rate--3.7%). The request indicates 
that the material is subject to duties under Section 301 of the Trade 
Act of 1974 (Section 301), depending on the country of origin. The 
applicable Section 301 decisions require subject merchandise to be 
admitted to FTZs in privileged foreign status (19 CFR 146.41).
    Public comment is invited from interested parties. Submissions 
shall be addressed to the Board's Executive Secretary and sent to: 
<a href="/cdn-cgi/l/email-protection#99ffede3d9edebf8fdfcb7fef6ef"><span class="__cf_email__" data-cfemail="0f697b754f7b7d6e6b6a21686079">[email protected]</span></a>. The closing period for their receipt is August 23, 2021.
    A copy of the notification will be available for public inspection 
in the ``Reading Room'' section of the Board's website, which is 
accessible via www.trade.gov/ftz.
    For further information, contact Diane Finver at 
<a href="/cdn-cgi/l/email-protection#f4b09d959a91dab29d9a829186b48086959091da939b82"><span class="__cf_email__" data-cfemail="de9ab7bfb0bbf098b7b0a8bbac9eaaacbfbabbf0b9b1a8">[email protected]</span></a>.

    Dated: July 8, 2021.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2021-14955 Filed 7-13-21; 8:45 am]
BILLING CODE 3510-DS-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>